Shots:
Camurus has reported topline P-IIb (POSITANO) trial data assessing 2 dosing regimens of CAM2029 (octreotide SC depot) vs PBO in 71 pts with symptomatic polycystic liver disease (PLD), with pts continuing treatment in a 2.5yr. OLE study
Trial met its 1EP with a 4.3% relative reduction in height-adjusted liver volume at Wk. 53 for…
